417 related articles for article (PubMed ID: 17043131)
1. Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
Chen S; Cui S; McDermott PF; Zhao S; White DG; Paulsen I; Meng J
Antimicrob Agents Chemother; 2007 Feb; 51(2):535-42. PubMed ID: 17043131
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the multidrug efflux operon acrEF by insertional activation with IS1 or IS10 elements in Salmonella enterica serovar typhimurium DT204 acrB mutants selected with fluoroquinolones.
Olliver A; Vallé M; Chaslus-Dancla E; Cloeckaert A
Antimicrob Agents Chemother; 2005 Jan; 49(1):289-301. PubMed ID: 15616308
[TBL] [Abstract][Full Text] [Related]
3. Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium.
Zheng J; Cui S; Meng J
J Antimicrob Chemother; 2009 Jan; 63(1):95-102. PubMed ID: 18984645
[TBL] [Abstract][Full Text] [Related]
4. The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar typhimurium phage type DT204.
Baucheron S; Imberechts H; Chaslus-Dancla E; Cloeckaert A
Microb Drug Resist; 2002; 8(4):281-9. PubMed ID: 12523625
[TBL] [Abstract][Full Text] [Related]
5. AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar typhimurium DT104.
Baucheron S; Tyler S; Boyd D; Mulvey MR; Chaslus-Dancla E; Cloeckaert A
Antimicrob Agents Chemother; 2004 Oct; 48(10):3729-35. PubMed ID: 15388427
[TBL] [Abstract][Full Text] [Related]
6. Using In Vitro Dynamic Models To Evaluate Fluoroquinolone Activity against Emergence of Resistant Salmonella enterica Serovar Typhimurium.
Lee SJ; Awji EG; Park NH; Park SC
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895011
[TBL] [Abstract][Full Text] [Related]
7. Role of TolC and parC mutation in high-level fluoroquinolone resistance in Salmonella enterica serotype Typhimurium DT204.
Baucheron S; Chaslus-Dancla E; Cloeckaert A
J Antimicrob Chemother; 2004 Apr; 53(4):657-9. PubMed ID: 14985270
[TBL] [Abstract][Full Text] [Related]
8. Fluoroquinolone treatment of experimental Salmonella enterica serovar Typhimurium DT104 infections in chickens selects for both gyrA mutations and changes in efflux pump gene expression.
Randall LP; Eaves DJ; Cooles SW; Ricci V; Buckley A; Woodward MJ; Piddock LJ
J Antimicrob Chemother; 2005 Aug; 56(2):297-306. PubMed ID: 15956100
[TBL] [Abstract][Full Text] [Related]
9. The role of intra- and extragenic compensatory mutations in the suppression of fluoroquinolone resistance in a Salmonella Typhimurium gyrA mutant (D87G).
Preisler A; Heisig P
J Antimicrob Chemother; 2009 Feb; 63(2):290-4. PubMed ID: 19033246
[TBL] [Abstract][Full Text] [Related]
10. Role of an acrR mutation in multidrug resistance of in vitro-selected fluoroquinolone-resistant mutants of Salmonella enterica serovar Typhimurium.
Olliver A; Vallé M; Chaslus-Dancla E; Cloeckaert A
FEMS Microbiol Lett; 2004 Sep; 238(1):267-72. PubMed ID: 15336432
[TBL] [Abstract][Full Text] [Related]
11. Contribution of enhanced efflux to reduced susceptibility of Salmonella enterica serovar Choleraesuis to fluoroquinolone and other antimicrobials.
Usui M; Uchiyama M; Baba K; Nagai H; Yamamoto Y; Asai T
J Vet Med Sci; 2011 Feb; 73(2):279-82. PubMed ID: 20953129
[TBL] [Abstract][Full Text] [Related]
12. The role of RamA on the development of ciprofloxacin resistance in Salmonella enterica serovar Typhimurium.
Sun Y; Dai M; Hao H; Wang Y; Huang L; Almofti YA; Liu Z; Yuan Z
PLoS One; 2011; 6(8):e23471. PubMed ID: 21858134
[TBL] [Abstract][Full Text] [Related]
13. In Vitro Development of Ciprofloxacin Resistance of Salmonella enterica Serovars Typhimurium, Enteritidis, and Indiana Isolates from Food Animals.
Zhang WH; Zhang CZ; Liu ZJ; Gu XX; Li W; Yang L; Liu YH; Zeng ZL; Jiang HX
Microb Drug Resist; 2017 Sep; 23(6):687-694. PubMed ID: 28085562
[TBL] [Abstract][Full Text] [Related]
14. ramR mutations involved in efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium.
Abouzeed YM; Baucheron S; Cloeckaert A
Antimicrob Agents Chemother; 2008 Jul; 52(7):2428-34. PubMed ID: 18443112
[TBL] [Abstract][Full Text] [Related]
15. Ciprofloxacin-resistant Salmonella enterica serovar Typhimurium strains are difficult to select in the absence of AcrB and TolC.
Ricci V; Tzakas P; Buckley A; Piddock LJ
Antimicrob Agents Chemother; 2006 Jan; 50(1):38-42. PubMed ID: 16377664
[TBL] [Abstract][Full Text] [Related]
16. Characterization of isolates of Salmonella enterica serovar typhimurium displaying high-level fluoroquinolone resistance in Japan.
Izumiya H; Mori K; Kurazono T; Yamaguchi M; Higashide M; Konishi N; Kai A; Morita K; Terajima J; Watanabe H
J Clin Microbiol; 2005 Oct; 43(10):5074-9. PubMed ID: 16207965
[TBL] [Abstract][Full Text] [Related]
17. TolC but not AcrB is essential for multidrug-resistant Salmonella enterica serotype Typhimurium colonization of chicks.
Baucheron S; Mouline C; Praud K; Chaslus-Dancla E; Cloeckaert A
J Antimicrob Chemother; 2005 May; 55(5):707-12. PubMed ID: 15814604
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the Fluoroquinolone Antibiotic Resistance Mechanism of Salmonella enterica Isolates.
Kim SY; Lee SK; Park MS; Na HT
J Microbiol Biotechnol; 2016 Sep; 26(9):1605-12. PubMed ID: 27116992
[TBL] [Abstract][Full Text] [Related]
19. Changes in antimicrobial susceptibility in a population of Salmonella enterica serovar Dublin isolated from cattle in Japan from 1976 to 2005.
Akiba M; Nakaoka Y; Kida M; Ishioka Y; Sameshima T; Yoshii N; Nakazawa M; Uchida I; Terakado N
J Antimicrob Chemother; 2007 Dec; 60(6):1235-42. PubMed ID: 17956907
[TBL] [Abstract][Full Text] [Related]
20. Role of global regulator Rma for multidrug efflux-mediated fluoroquinolone resistance in Salmonella.
Feuerriegel S; Heisig P
Microb Drug Resist; 2008 Dec; 14(4):259-63. PubMed ID: 19018673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
